Half-Life Cancer Research Results
Half-Life, Half-Life: Click to Expand ⟱
| Source: |
| Type: |
For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream.
In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects.
|
Wounds, Wounds: Click to Expand ⟱
Wounds: Injury to the body, such as the skin.
|
Scientific Papers found: Click to Expand⟱
*Inflam↓, *antiOx↑, *ROS↓, *angioG↑, *COL1↑, *α-SMA↑, *TGF-β↑, *BMD↑, *hepatoP↑, *TNF-α↑, *HSP70/HSPA5↑, *SOD↑, *Catalase↑, *GSH↑, *MDA↓, *TOS↓, *IL6↓, *JAK2↓, *STAT3↓, *AMPK↑, *lipid-P↓, *VEGF↑, *Half-Life↝,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Total Targets: 0
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, Catalase↑, 1, GSH↑, 1, lipid-P↓, 1, MDA↓, 1, ROS↓, 1, SOD↑, 1, TOS↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1,
Protein Folding & ER Stress ⓘ
HSP70/HSPA5↑, 1,
Proliferation, Differentiation & Cell State ⓘ
STAT3↓, 1,
Migration ⓘ
COL1↑, 1, TGF-β↑, 1, α-SMA↑, 1,
Angiogenesis & Vasculature ⓘ
angioG↑, 1, VEGF↑, 1,
Immune & Inflammatory Signaling ⓘ
IL6↓, 1, Inflam↓, 1, JAK2↓, 1, TNF-α↑, 1,
Drug Metabolism & Resistance ⓘ
Half-Life↝, 1,
Clinical Biomarkers ⓘ
BMD↑, 1, IL6↓, 1,
Functional Outcomes ⓘ
hepatoP↑, 1,
Total Targets: 24
Scientific Paper Hit Count for: Half-Life, Half-Life
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:37 Cells:% prod#:% Target#:1109 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page